Mechanotransduction of platelet receptors GPIb and GPIIb-IIIa
血小板受体 GPIb 和 GPIIb-IIIa 的机械转导
基本信息
- 批准号:10298451
- 负责人:
- 金额:$ 52.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAffinityAgonistAntiplatelet DrugsArteriesBindingBiochemicalBiomechanicsBlood Coagulation DisordersBlood PlateletsBlood VesselsBlood flowClinicalCuesCytoplasmic TailDataFibrinogenFunctional disorderG13 ProteinGlycoprotein IbGrantHemorrhageHemostatic AgentsHemostatic functionImpairmentIntegrinsKnock-in MouseKnowledgeLigand BindingLigandsMechanicsMechanoreceptorsMediatingMembraneMolecular ConformationMutationParticipantPathologyPhysiologyPlatelet ActivationProcessProteinsRegulationReportingRoleSideSignal PathwaySignal TransductionSurfaceTalinTestingTherapeuticThrombosisThrombusWorkadhesion receptordesignfilaminin vivoinsightmechanotransductionreceptorside effectsynergismthromboticvon Willebrand Factor
项目摘要
Project Summary/Abstract
Platelets are arguably the most important cellular participant in hemostasis and thrombosis. Many therapeutic
strategies target platelet molecules to inhibit their functions in thrombosis. In particular, two membrane adhesion
receptors, glycoprotein (GP) Ib-IX and GPIIb-IIIa (integrin IIb3), cooperatively mediate platelet adhesion and
thrombus formation under high shear flow, and thus are ideal targets for inhibiting thrombosis in stenotic arteries
as well as in microvasculature. Also, all anti-platelet drugs currently being used to treat thrombosis clinically have
adverse hemorrhagic side effects, because the platelet plug formation required to stop bleeding is also inhibited.
Under the support of this grant in its past period, we and others showed that both GPIbα and IIb3 are
mechanoreceptors capable of receiving mechanical cues. We found that GPIb mechano-signaling leads to
integrin inside-out signaling, which activates IIb3 from the inactive state having a bent conformation and a
closed headpiece (BC) with a low affinity and short bond lifetime for ligand to an intermediate state having an
extended conformation but a closed headpiece (EC) with an intermediate affinity and intermediate bond lifetime
for ligand, which is distinct from the fully active state of IIb3 often seen in platelets stimulated by soluble agonists
that has an extended conformation and an open headpiece (EO) with a high affinity and long bond lifetime for
ligand. Significantly, the intermediate state of IIb3 mediates the formation of “biomechanical thrombi”, consisting
of transient and unstable platelet aggregates resembling the dynamic outer layer of an in vivo thrombus formed
under high shear blood flow, which is distinct from platelet aggregates underneath the outer layer that are further
stimulated by released soluble agonists and where IIb3 are further activated to the fully active EO state. Further
activation from the intermediate state to the fully active state can also be induced by IIb3 outside-in mechano-
signaling, which also induces further activation of platelets. These data highlight the role of force-induced
signaling – mechano-signaling – of, by, and between GPIb-IX and IIb3, and their unique importance in thrombus
formation. Our overarching hypothesis is that a balanced regulation of mechano-signals of GPIbα and IIb3, and
their synergy with biochemical signals induced by soluble platelet agonists, holds the promise to control
thrombosis without unsetting hemostasis. The specific aims are to elucidate 1) the roles of 14-3-3ζ and filamin
A on GPIbα ligand-binding, unfolding and mechano-signaling, 2) the mechanism of GPIb-IX mechanosensing-
induced intracellular signaling pathway leading to integrin activation, and 3) the roles of G13, talin1 and Rap1
on GPIIb-IIIa binding, conformation and mechano-signaling. These studies will characterize the ligand-binding
and signaling of of two major platelet mechanoreceptors, GPIb and GPIIb-IIIa, as related to hemostasis and thrombosis.
The results will provide insights into vascular physiology and pathology and help develop therapeutic strategies
to treat thrombus formation with minimal adverse bleeding side effects.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheng Zhu其他文献
Cheng Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cheng Zhu', 18)}}的其他基金
Mechanotransduction of platelet receptors GPIb and GPIIb-IIIa
血小板受体 GPIb 和 GPIIb-IIIa 的机械转导
- 批准号:
10458027 - 财政年份:2016
- 资助金额:
$ 52.19万 - 项目类别:
Mechanotransduction of platelet receptors GPIb and GPIIb-IIIa
血小板受体 GPIb 和 GPIIb-IIIa 的机械转导
- 批准号:
10670136 - 财政年份:2016
- 资助金额:
$ 52.19万 - 项目类别:
Structural bases of ADAMTS-13 and VWF A2 interactions
ADAMTS-13 和 VWF A2 相互作用的结构基础
- 批准号:
8019207 - 财政年份:2011
- 资助金额:
$ 52.19万 - 项目类别:
Structural bases of ADAMTS-13 and VWF A2 interactions
ADAMTS-13 和 VWF A2 相互作用的结构基础
- 批准号:
8410081 - 财政年份:2011
- 资助金额:
$ 52.19万 - 项目类别:
Structural bases of ADAMTS-13 and VWF A2 interactions
ADAMTS-13 和 VWF A2 相互作用的结构基础
- 批准号:
8209109 - 财政年份:2011
- 资助金额:
$ 52.19万 - 项目类别:
STRUCTURAL MECHANISM OF INTEGRIN ACTIVATIN INDUCED BY TALIN
TALIN诱导整合素激活素的结构机制
- 批准号:
8364189 - 财政年份:2011
- 资助金额:
$ 52.19万 - 项目类别:
MOLECULAR SIMULATIONS OF INTEGRIN CONFORMATIONAL CHANGE
整合素构象变化的分子模拟
- 批准号:
7956229 - 财政年份:2009
- 资助金额:
$ 52.19万 - 项目类别:
Mechanical Regulation of Binding and Cleavage of VWF by ADAMTS-13
ADAMTS-13 对 VWF 结合和裂解的机械调节
- 批准号:
7663571 - 财政年份:2009
- 资助金额:
$ 52.19万 - 项目类别:
MD SIMULATIONS OF MECHANICAL REGULATION OF BIOMOLECULAR INTERACTIONS
生物分子相互作用机械调节的 MD 模拟
- 批准号:
7956219 - 财政年份:2009
- 资助金额:
$ 52.19万 - 项目类别:
Mechanical Regulation of Binding and Cleavage of VWF by ADAMTS-13
ADAMTS-13 对 VWF 结合和裂解的机械调节
- 批准号:
8274715 - 财政年份:2009
- 资助金额:
$ 52.19万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 52.19万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 52.19万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 52.19万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 52.19万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 52.19万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 52.19万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 52.19万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 52.19万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 52.19万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 52.19万 - 项目类别: